These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 38627829)

  • 1. Gut microbiota-host lipid crosstalk in Alzheimer's disease: implications for disease progression and therapeutics.
    Luo YX; Yang LL; Yao XQ
    Mol Neurodegener; 2024 Apr; 19(1):35. PubMed ID: 38627829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota modulation in Alzheimer's disease: Focus on lipid metabolism.
    Bonfili L; Cuccioloni M; Gong C; Cecarini V; Spina M; Zheng Y; Angeletti M; Eleuteri AM
    Clin Nutr; 2022 Mar; 41(3):698-708. PubMed ID: 35158177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the Microbiota-Gut-Brain Axis on Cognition in Alzheimer's Disease.
    Escobar YH; O'Piela D; Wold LE; Mackos AR
    J Alzheimers Dis; 2022; 87(1):17-31. PubMed ID: 35253750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota defined epigenomes of Alzheimer's and Parkinson's diseases reveal novel targets for therapy.
    Nohesara S; Abdolmaleky HM; Thiagalingam S; Zhou JR
    Epigenomics; 2024 Jan; 16(1):57-77. PubMed ID: 38088063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.
    Goyal D; Ali SA; Singh RK
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110112. PubMed ID: 32949638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gut microbiota during the progression of atherosclerosis in the perimenopausal period shows specific compositional changes and significant correlations with circulating lipid metabolites.
    Meng Q; Ma M; Zhang W; Bi Y; Cheng P; Yu X; Fu Y; Chao Y; Ji T; Li J; Chen Q; Zhang Q; Li Y; Shan J; Bian H
    Gut Microbes; 2021; 13(1):1-27. PubMed ID: 33691599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota and its Metabolites: Bridge of Dietary Nutrients and Alzheimer's Disease.
    Zhu G; Zhao J; Zhang H; Wang G; Chen W
    Adv Nutr; 2023 Jul; 14(4):819-839. PubMed ID: 37075947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional effects of gut microbiota-derived metabolites in Alzheimer's disease.
    Choi H; Mook-Jung I
    Curr Opin Neurobiol; 2023 Aug; 81():102730. PubMed ID: 37236067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of gut and oral microbiota in neuroinflammatory responses in Alzheimer's disease.
    Bello-Corral L; Alves-Gomes L; Fernández-Fernández JA; Fernández-García D; Casado-Verdejo I; Sánchez-Valdeón L
    Life Sci; 2023 Nov; 333():122132. PubMed ID: 37793482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
    Nagu P; Parashar A; Behl T; Mehta V
    J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic Acid and the Gut Microbiota in Alzheimer's Disease: Fighting Back-to-Back?
    Endres K
    Curr Alzheimer Res; 2019; 16(5):405-417. PubMed ID: 30907321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota and pro/prebiotics in Alzheimer's disease.
    Pluta R; Ułamek-Kozioł M; Januszewski S; Czuczwar SJ
    Aging (Albany NY); 2020 Mar; 12(6):5539-5550. PubMed ID: 32191919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting gut microbiota to alleviate neuroinflammation in Alzheimer's disease.
    Thu Thuy Nguyen V; Endres K
    Adv Drug Deliv Rev; 2022 Sep; 188():114418. PubMed ID: 35787390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory pathways in Alzheimer's disease mediated by gut microbiota.
    Qian XH; Song XX; Liu XL; Chen SD; Tang HD
    Ageing Res Rev; 2021 Jul; 68():101317. PubMed ID: 33711509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysbiosis and Alzheimer's Disease: Cause or Treatment Opportunity?
    Janeiro MH; Ramírez MJ; Solas M
    Cell Mol Neurobiol; 2022 Mar; 42(2):377-387. PubMed ID: 33400081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary lipids, gut microbiota and lipid metabolism.
    Schoeler M; Caesar R
    Rev Endocr Metab Disord; 2019 Dec; 20(4):461-472. PubMed ID: 31707624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Microbiota-Gut-Brain Axis and Alzheimer's Disease: Neuroinflammation Is to Blame?
    Megur A; Baltriukienė D; Bukelskienė V; Burokas A
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acids and beyond: Age and Alzheimer's disease related changes in lipids reveal the neuro-nutraceutical potential of lipids in cognition.
    Ooi KM; Vacy K; Boon WC
    Neurochem Int; 2021 Oct; 149():105143. PubMed ID: 34311029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of Gut Microbiota to Immunological Changes in Alzheimer's Disease.
    van Olst L; Roks SJM; Kamermans A; Verhaar BJH; van der Geest AM; Muller M; van der Flier WM; de Vries HE
    Front Immunol; 2021; 12():683068. PubMed ID: 34135909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota and Alzheimer's Disease: Pathophysiology and Therapeutic Perspectives.
    Li Y; Wang R; Li Q; Wang YJ; Guo J
    J Alzheimers Dis; 2021; 83(3):963-976. PubMed ID: 34366348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.